COMBINATION OF MARKERS AT THE ESTROGEN- AND VITAMIN D-RECEPTOR GENES OR EQUIVALENTS THEREOF TO PROGNOSE A RESPONSE TO OSTEOPOROSIS THERAPY - Patent 1114181

(19)

(11)

EP 1 114 181 A2

(12)

(88)	Date of publication A3:
	08.06.2000

(43)	Date of publication:
	11.07.2001 Bulletin 2001/28

(21)	Application number: 99944190.0

(22)	Date of filing: 15.09.1999

(51)	International Patent Classification (IPC)⁷: C12Q 1/68

(86)	International application number:
	PCT/CA9900/854

(87)	International publication number:
	WO 0015/836 (23.03.2000 Gazette 2000/12)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

15.09.1998 US 100446 P

(71)	Applicant: Signalgene Inc.
	Montreal,Quebec H2M 2N9 (CA)

(72)	Inventor:
	ROUSSEAU, François Sainte-Foy, Quebec G1W 1M7 (CA)

(74)	Representative: Best, Michael, Dr. et al
	Lederer, Keller & RiedererPatentanwältePrinzregentenstrasse 16 80538 München 80538 München (DE)

(54)	COMBINATION OF MARKERS AT THE ESTROGEN- AND VITAMIN D-RECEPTOR GENES OR EQUIVALENTS THEREOF TO PROGNOSE A RESPONSE TO OSTEOPOROSIS THERAPY